CN106036435A - 学生及电脑族用健康粥粉及其制备方法 - Google Patents
学生及电脑族用健康粥粉及其制备方法 Download PDFInfo
- Publication number
- CN106036435A CN106036435A CN201610587945.7A CN201610587945A CN106036435A CN 106036435 A CN106036435 A CN 106036435A CN 201610587945 A CN201610587945 A CN 201610587945A CN 106036435 A CN106036435 A CN 106036435A
- Authority
- CN
- China
- Prior art keywords
- parts
- semen
- porridge powder
- student
- cybraian
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 70
- 235000021395 porridge Nutrition 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 210000000582 semen Anatomy 0.000 claims abstract description 306
- 244000269722 Thea sinensis Species 0.000 claims abstract description 45
- 235000009569 green tea Nutrition 0.000 claims abstract description 42
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 41
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 41
- 235000009566 rice Nutrition 0.000 claims abstract description 39
- 235000021329 brown rice Nutrition 0.000 claims abstract description 33
- 244000268590 Euryale ferox Species 0.000 claims abstract description 31
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 30
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 23
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 23
- 239000008103 glucose Substances 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 229930006000 Sucrose Natural products 0.000 claims abstract description 16
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 16
- 238000003756 stirring Methods 0.000 claims abstract description 16
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 14
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 14
- 239000011648 beta-carotene Substances 0.000 claims abstract description 14
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 14
- 229960002747 betacarotene Drugs 0.000 claims abstract description 14
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 14
- 239000012467 final product Substances 0.000 claims abstract description 8
- 230000036541 health Effects 0.000 claims description 49
- 102000002322 Egg Proteins Human genes 0.000 claims description 40
- 108010000912 Egg Proteins Proteins 0.000 claims description 40
- 235000013345 egg yolk Nutrition 0.000 claims description 40
- 241000209094 Oryza Species 0.000 claims description 38
- 101100381997 Danio rerio tbc1d32 gene Proteins 0.000 claims description 30
- 101100381999 Mus musculus Tbc1d32 gene Proteins 0.000 claims description 30
- 238000001035 drying Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 3
- 235000013601 eggs Nutrition 0.000 claims description 2
- 230000007159 enucleation Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 32
- 208000001491 myopia Diseases 0.000 abstract description 14
- 230000004379 myopia Effects 0.000 abstract description 13
- 208000008589 Obesity Diseases 0.000 abstract description 11
- 235000020824 obesity Nutrition 0.000 abstract description 11
- 230000012010 growth Effects 0.000 abstract description 10
- 244000062793 Sorghum vulgare Species 0.000 abstract description 4
- 235000019713 millet Nutrition 0.000 abstract description 4
- 240000007594 Oryza sativa Species 0.000 abstract description 3
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract description 2
- 235000019640 taste Nutrition 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 2
- 240000008620 Fagopyrum esculentum Species 0.000 abstract 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 abstract 1
- 244000068988 Glycine max Species 0.000 abstract 1
- 235000010469 Glycine max Nutrition 0.000 abstract 1
- 235000013402 health food Nutrition 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 26
- 210000000952 spleen Anatomy 0.000 description 22
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 210000001508 eye Anatomy 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 230000007774 longterm Effects 0.000 description 10
- 206010049865 Achromotrichia acquired Diseases 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 230000004438 eyesight Effects 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000013872 defecation Effects 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 206010048222 Xerosis Diseases 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 230000035943 smell Effects 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 201000004384 Alopecia Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010062575 Muscle contracture Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 208000019902 chronic diarrheal disease Diseases 0.000 description 3
- 208000006111 contracture Diseases 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008631 Cholera Diseases 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010047531 Visual acuity reduced Diseases 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 208000003464 asthenopia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 244000201986 Cassia tora Species 0.000 description 1
- 235000014552 Cassia tora Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 241001426056 Eleusine coracana subsp. coracana Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000007199 Panicum miliaceum Nutrition 0.000 description 1
- 241000207960 Pedaliaceae Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010064996 Ulcerative keratitis Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 229940106705 chlorophyll Drugs 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000004402 high myopia Effects 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003601 intercostal effect Effects 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000004315 low visual acuity Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- -1 phylloxanthin Chemical compound 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
学生及电脑族用健康粥粉及其制备方法,属于保健食品技术领域。小米8~10份、荞麦5~7份、芡实1~3份、蛋黄4~6份、糙米3~5份、黑糯米11~13份、燕麦2~4份、莲子2~4份、薏米4~6份、山药3~5份、黑豆4~6份、枸杞子2~4份、绿茶1~3份、红枣1~3份、黑芝麻5~7份、杏仁0.5~1.5份、核桃仁4~6份、决明子油0.3~1份、β‑胡萝卜素0.5~1.5份、绵白糖4~6份、葡萄糖15~17份。制备方法采用分别烘烤至酥脆,再加入决明子油,经粉碎、过筛、加糖、搅匀获得。该学生及电脑族用健康粥粉对于近视眼、肥胖症和生长障碍均有较好的疗效,无副作用,并且具有较好的服用口感。
Description
技术领域
学生及电脑族用健康粥粉及其制备方法,属于保健食品技术领域。
背景技术
粥粉是我国食粥的特色,对增进国民的健康发挥着更为重要的作用,通过加水后煮食的方式服用,具有养生食疗效用的一类粥品。
申请人在研究中发现现有的粥粉存在以下问题:首先,近视眼、肥胖症和生长障碍为学生及电脑族常见的疾病,给患者的正常生活带来较大的不便,现有的粥粉在治疗以上病症时效果并不理想。学生学业繁重,读、写、画、算无不是用眼睛,尤其是现在以考试为导向的教育,导致了眼睛长期处在疲劳状态.据调查我国现有盲人500多万,低视力近千万人,尤其是在儿童及青少年当中,患病率极高。全国学生体质健康调研最新数据表明,我国小学生近视眼发病率为22.78 %,中学生为55.22 %,高中生为70.34 %。更令人震惊的是,有份调查报告称,国内因高度近视致盲者已达30多万人。因此儿童及青少年近视的防治越来越为学生、家长及社会所关注。如今的上班族,每天工作时间8小时对着电脑,下班休闲娱乐也几乎离不开电脑手机。长期面对电子屏幕的眼睛,很容易出现损耗、疲劳、酸涩,加重近视度数,长期下去会导致多种眼疾,严重者会损伤眼底,有失明致盲危险。
其次,现有的粥粉需长期服用获得食疗效果,但现有的粥粉口感不佳,导致患者服用积极性较低,无法坚持长期服用,难以达到预期的疗效。现有的粥粉在实际生产中常添加防腐剂、增稠剂、香精,以延长粥粉的储藏时间、改善粥粉冲泡后的口感,长期服用不利于人体健康。
发明内容
本发明要解决的技术问题是:克服现有技术的不足,提供学生及电脑族用健康粥粉及其制备方法,该学生及电脑族用健康粥粉对于近视眼、肥胖症和生长障碍均有较好的疗效,无副作用,并且具有较好的服用口感。
本发明解决其技术问题所采用的技术方案是:该学生及电脑族用健康粥粉,包括以下重量份的原料:小米8~10份、荞麦5~7份、芡实1~3份、蛋黄4~6份、糙米3~5份、黑糯米11~13份、燕麦2~4份、莲子2~4份、薏米4~6份、山药3~5份、黑豆4~6份、枸杞子2~4份、绿茶1~3份、红枣1~3份、黑芝麻5~7份、杏仁0.5~1.5份、核桃仁4~6份、决明子油0.3~1份、β-胡萝卜素0.5~1.5份、绵白糖4~6份、葡萄糖15~17份。
优选的,该学生及电脑族用健康粥粉,其特征在于,包括以下重量份的原料:小米8.5~9.5份、荞麦5.5~6.5份、芡实1.5~2.5份、蛋黄4.5~5.5份、糙米3.5~4.5份、黑糯米11.5~12.5份、燕麦2.5~3.5份、莲子2.5~3.5份、薏米4.5~5.5份、山药3.5~4.5份、黑豆4.5~5.5份、枸杞子2.5~3.5份、绿茶1.5~2.5份、红枣1.5~2.5份、黑芝麻5.5~6.5份、杏仁0.8~1.2份、核桃仁4.5~5.5份、决明子油0.4~0.8份、β-胡萝卜素0.8~1.2份、绵白糖4.5~5.5份、葡萄糖16~17份。
优选的,该学生及电脑族用健康粥粉,其特征在于,包括以下重量份的原料:小米9份、荞麦6份、芡实2份、蛋黄5份、糙米4份、黑糯米12份、燕麦3份、莲子3份、薏米5份、山药4份、黑豆5份、枸杞子3份、绿茶2份、红枣2份、黑芝麻6份、杏仁1份、核桃仁5份、决明子油0.5份,β-胡萝卜素1份、绵白糖5份、葡萄糖16.5份。
所述的红枣为去核红枣,莲子为去莲芯的莲子,山药为去皮山药。
所述的蛋黄为鸡蛋黄。
该学生及电脑族用健康粥粉的制备方法,其特征在于,包括以下步骤:
1)将小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁和核桃仁,分别烘烤至酥脆,待用;将蛋黄煮熟、加热烘干,待用;
2)按重量份配比称量烘烤后的小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁、核桃仁和蛋黄,加入决明子油,搅拌混合,粉碎,过120~200目筛得细粉,加入葡萄糖搅拌均匀,即得。
步骤1)所述的杏仁在烘烤前,先加水浸泡24小时。
步骤2)中采用过150目筛得细粉。
申请人对本发明的说明如下:原料配方中的小米、荞麦、芡实、蛋黄、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁、核桃仁的重量份为烘烤后的重量。
小米,气味咸,微寒,无毒;主治:可以养肾气,除脾胃中热,利小便,治痢疾。磨成粉可以解毒,止霍乱。做粥食用可以开胃补虚。《本草纲目》记载:“养肾气,去脾胃中热,益气。陈者:苦,寒。治胃热消渴,利小便。” 常吃谷子可降血压、补血健脑、安眠。减轻皱色素沉积的美容功效。区别于黄谷子,红谷子和黑谷子滋阴补血、乌发防衰老之功能。
荞麦,性甘味凉,有开胃宽肠,下气消积。治绞肠痧,肠胃积滞,慢性泄泻的功效;长期食用具有明显的降压作用。
芡实,为睡莲科植物芡的干燥成熟种仁。具有益肾固精,补脾止泻,除湿止带之功效。常用于遗精滑精,遗尿尿频,脾虚久泻,白浊,带下。
糙米,是稻谷脱去外保护皮层稻壳后的颖果,内保护皮层完好的稻米籽粒。味甘、性温,健脾养胃、补中益气,调和五脏、镇静神经、促进消化吸收。糙米中米糠和胚芽部分的维生素B和维生素E,能提高人体免疫功能,促进血液循环,还能帮助人们消除沮丧烦躁的情绪,使人充满活力。糙米中的微量元素钾、镁、锌、铁、锰,可有利于预防心血管疾病和贫血症。糙米中的微量元素锌、铬、锰、钒,可有利于提高胰岛素的敏感性,对糖耐量受损的人很有帮助它还保留了大量膳食纤维,可促进肠道有益菌增殖,加速肠道蠕动,软化粪便,预防便秘和肠癌;膳食纤维还能与胆汁中胆固醇结合,促进胆固醇的排出,从而帮助高血脂症患者降低血脂。大量膳食纤维可包覆碳水化合物有效控制血糖。
黑糯米,味甘、性温,入脾、胃、肺经;具有温补强壮、补中益气、健脾养胃、止虚汗、缓解食欲不佳的功效。适用于脾胃虚寒所致的反胃、食欲减少、泄泻和气虚引起的汗出、气短无力、妊娠腹坠胀。适宜肺结核、神经衰弱、病后产后之人食用。黑糯米中富含花青素,具有抗氧化、抗突变、抑制肿瘤、保护心脑血管疾病、保护肝脏的作用,可用于治疗抗糖尿病性视网膜病、乳房囊肿,治疗由毛细血管脆弱引起的微循环疾病,保持血管的正常通透性,还可以用于预防胆固醇引起的兔的动脉粥样硬化。申请人在研究中发现:现有的即食粥粉食用时存在口感不佳的问题,导致患者不能坚持长期服用,最终无法达到预期的疗效。申请人设计添加黑糯米,区别于紫色或黑色大米,黑糯米还具有糯米特有的糯性,能够明显改善粥粉冲泡后的口感,使其口感香甜软糯,口感的改善能够提高患者长期服用的积极性,从而提高治疗效果。黑糯米11~13份的用量为申请人讲究后确定,黑糯米添加过少则冲泡后粥品粘度过低、口感不佳,黑糯米添加过多则口感过于粘稠、不符合学生和电脑族(主要为10~45岁年龄段人群)的口感要求,黑糯米11~13份的用量为最佳用量,不但营养均衡,且最符合学生及电脑族的口感要求。
燕麦,具有降低血压、降低胆固醇、防治大肠癌、防治心脏疾病的医疗价值和保健作用。对于因肝、肾病变、糖尿病、脂肪肝引起的继发性高脂血症也有同样明显的疗效。燕麦中富含β-葡聚糖,它能够活化巨噬细胞、嗜中性白血球,因此能提高白细胞素、细胞分裂素和特殊抗体的含量,全面刺激机体的免疫系统。此外,葡聚糖还有清除游离基、抗辐射、溶解胆固醇,预防高脂血症作用及抵抗滤过性病毒、真菌、细菌引起的感染。
莲子,为睡莲科植物莲的干燥成熟种子。分布于我国南北各省。具有补脾止泻,止带,益肾涩精,养心安神之功效。常用于脾虚泄泻,带下,遗精,心悸失眠。
薏米,又叫薏苡仁。性味甘淡、微寒、无毒。入脾、胃、肺、大肠。功效清热利湿,除风湿,利小便,益肺排脓,健脾胃,强筋骨。主治风湿身痛,湿热脚气,湿热筋急拘挛,湿痹,水肿,肺萎肺痈,咳吐脓血,喉痹痈肿,肠痈热淋。
山药,性味 甘,平。 归脾、肺、肾经。功能主治补脾养胃,生津益肺,补肾涩精。用于脾虚食少,久泻不止,肺虚喘咳,肾虚遗精,带下,尿频,虚热消渴。
黑豆,味甘,性微寒。能补肾益阴,健脾利湿,除热解毒,止咳平喘。用于肾虚阴亏,消渴多饮,小便频数;肝肾阴虚,头晕目眩,视物昏暗,或须发早白;脚气水肿,或湿痹拘挛、腰痛;腹中挛急作痛或泻痢腹痛。黑豆含有丰富的营养元素如蛋白质、脂肪酸和维生素,具有降血脂、抗氧化、降胆固醇,预防心血管、促进排便、养颜美容,患有肥胖症的患者吃,有利于壮阳和减肥。
枸杞子,性甘,平。归肝、肾经。功能主治:滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明。主五内邪气,热中消渴,周痹风湿。久服坚筋骨,轻身不老,能耐寒暑。
绿茶,指采取茶树的新叶或芽,未经发酵,经杀青、整形、烘干工艺制作而成。其制成品的色泽和冲泡后的茶汤较多的保存了鲜茶叶的绿色格调。绿茶能防癌,降脂和减肥,对吸烟者也可减轻其受到的尼古丁伤害。绿茶富含茶多酚、儿茶素、叶绿素、咖啡碱、氨基酸和多种维生素,这些天然营养成份有较好的防衰老、防癌、抗癌、杀菌和消炎效果。优选的,绿茶为日照绿茶、龙井绿茶、碧罗春绿茶、信阳毛尖绿茶、黄山毛峰绿茶、庐山云雾绿茶、六安瓜片绿茶、蒙顶绿茶、太平猴魁绿茶中的一种或多种。
红枣,即大枣,性甘,温。归脾、胃经。功能主治:补中益气,养血安神。用于脾虚食少,乏力便溏,妇人脏躁。
黑芝麻,为胡麻科芝麻的黑色种子,含有大量的脂肪和蛋白质,还含有糖类、维生素A、维生素E、卵磷脂,以及微量元素钙、铁、铬。有健胃、保肝、促进红细胞生长的作用,同时可以增加体内黑色素,有利于头发生长。
杏仁,性味苦,温。止咳平喘,润肠通便。适宜于风邪、肠燥实证之患。凡阴亏、郁火者。杏仁与其他粮食类成分联用具有降低胆固醇水平的作用。
核桃仁,含有人体必需的多种微量元素(钙、磷、铁)和矿物质,以及类胡萝卜素、核黄素,还含有良性蛋白质——亚麻酸,具有补血、养血、益脑的功效。
蛋黄,富含脂溶性维生素,单不饱和脂肪酸,多种微量元素(磷、铁)。蛋黄中有宝贵的维生素A和维生素D,还有维生素E和维生素K,这些都是“脂溶性维生素”。水溶性的维生素B族,也绝大多数存在于蛋黄之中。而蛋黄之所以呈浅黄色,就是因为它含有核黄素,而核黄素就是维生素B2,它可以预防烂嘴角、舌炎、嘴唇裂口。蛋黄中富含类胡萝素,叶黄素和玉米黄素都属于类胡萝卜素,但是它们不能在人体内转变成维生素A。虽说如此,它们却具有很强的抗氧化作用,特别是保护眼睛的作用,能够帮助眼睛过滤有害的紫外线,延缓眼睛的老化,预防视网膜黄斑变性和白内障,对心脏也很有好处。优选的,蛋黄为鸡蛋黄,鸡蛋黄是由散养的家鸡、野鸡所产的鸡蛋的蛋黄。
决明子油,为决明子中提取的挥发油。决明子油具有清肝火、祛风湿、益肾明目、通便的功能。主治高血压、头痛、眩晕、急性结膜炎、角膜溃疡、青光眼、痈疖疮疡。决明子又称“还瞳子”,决明子含有多种维生素和丰富的氨基酸、脂肪、碳水化合物等,近年来其保健功能日益受到人们的重视。决明子具有等功能,常饮决明子茶,可使血压正常,大便通畅,改善视力,对于肥胖症和近视眼均有较好的疗效。
本发明的配方中添加了β-胡萝卜素、绵白糖和葡萄糖。其中β-胡萝卜素0.5~1.5份配合枸杞子、蛋黄和决明子油,提高了对近视眼的治疗效果。绵白糖,主要成分为蔗糖。葡萄糖,是自然界分布最广且最为重要的一种单糖。申请人设计添加绵白糖4~6份、葡萄糖15~17份的用量,用于改善该健康粥粉的口感,该用量下健康粥粉的甜度适中,患者最易于接受。
申请人在研究中发现:影响学生及电脑族身体健康的有三大问题,一是气、二是湿、三是眼睛。气滞不畅,久积而致病。由于气所运行都是人体五脏六腑的要害部位,气滞而引发的都是大病。人体一般自然排放的都是肠胃之气,因此屁排放都是臭气,而肝胆积滞之气不易排放,健康粥粉能调理内分泌,促进新陈代谢,使二便通畅、规律。每天不仅能排出肠胃之气,放出臭屁;而且放不臭的屁,排出积滞的肝胆之气。湿在人体内,积而邪湿,易导致风湿、类风湿病、关节炎、痛风,服用健康粥粉后可除邪湿,由湿导致的病痛。学生及电脑族用健康粥粉,含有丰富的蛋白质、矿物质和微量元素,服用后可增强免疫力,强身健体,促进生长发育。尤其是含有丰富的维生素A、叶黄素、玉米黄素、决明子素,能起到防护电子荧屏辐射,缓解久视用眼疲劳,过滤紫外线,能有效的保护眼睛;预防和治疗近视眼;同时蛋黄和黑豆中还含有丰富的卵磷脂,能醒脑益智,丰富的维生素A和维生素E能清除体内自由基,减少皮肤褶皱增强弹性,起到护肤养颜美容作用。
在制备方法中,申请人在步骤1)中采用各种原料分别烘烤的方式,制成熟料,所得学生及电脑族用健康粥粉开水冲泡即可食用,方便患者服用,提高患者服用的积极性。优选的,步骤1)中小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、黑豆和黑芝麻的烘烤条件为100℃烘烤,烤至酥脆(含水率小于等于5%)停止烘烤;步骤1)中莲子、红枣、枸杞子、核桃仁的烘烤条件为90℃烘烤,烤至酥脆(含水率小于等于5%)停止烘烤;步骤1)中绿茶的烘烤条件为70℃烘烤,烤至酥脆(含水率小于等于5%)停止烘烤;步骤1)中杏仁和山药的烘烤条件为先70℃烘烤、再100℃烘烤,烤至酥脆(含水率小于等于5%)停止烘烤;步骤1)中蛋黄的烘烤条件为先70℃烘烤、再90℃烘烤,烤至酥脆(含水率小于等于1%)停止烘烤。优选的,步骤1)中的原料糙米、黑糯米、小米、荞麦、芡实、燕麦、薏米、黑豆、黑芝麻、莲子、红枣、枸杞子、山药、杏仁、核桃仁和绿茶在进行烘烤前,先进行冲洗、灭菌。步骤1)中烘烤采用烤箱进行。
申请人在步骤2)中设计过筛目数为120~200目,优选为150目,为最佳过筛目数,所得健康粥粉口感好、便于冲泡、又能促进消化。如果该健康粥粉颗粒过小,会过分破坏粥粉中丰富的粗纤维,粥粉促进肠道蠕动的功能降低;如果该健康粥粉颗粒过大,粥粉中营养成分被人体的吸收效果变差,服用口感不佳。优选的,步骤2)中搅拌混合设备为搅拌器,步骤2)中粉碎设备为杂粮粉碎机。
与现有技术相比,本发明的学生及电脑族用健康粥粉及其制备方法所具有的有益效果是:
1、本发明的学生及电脑族用健康粥粉对于近视眼、肥胖症和生长障碍均有较好的疗效,无副作用,并且具有较好的服用口感。申请人在考虑到营养搭配的同时,还添加了黑糯米和葡萄糖,以改善该中老年用健康粥粉的口感,冲泡后气味香浓、口感香甜软糯、柔滑,既便于营养的消化和吸收,又有助于提高患者长期服用的积极性,长期服用有助于获得较好的疗效。
2、本发明的学生及电脑族用健康粥粉不添加香精、植脂末、色素和防腐剂,长期服用无副作用。患者只需每日餐后作为营养粥服用即可实现治病强身的效果。
3、本发明的学生及电脑族用健康粥粉的制备方法简便易行,烘烤后的健康粥粉香气浓郁,开水冲泡后即可食用,并且冲泡而成的粥品口感香甜软糯,柔滑,有助于提高患者长期服用的积极性。
具体实施方式
实施例1~5是本发明的学生及电脑族用健康粥粉及其制备方法的具体实施例,其中实施例5为最佳实施方式。
实施例1
由以下重量份的原料制成:包括以下重量份的原料:小米8份、荞麦7份、芡实1份、蛋黄6份、糙米3份、黑糯米13份、燕麦2份、莲子4份、薏米4份、山药5份、黑豆4份、枸杞子4份、绿茶1份、红枣3份、黑芝麻5份、杏仁1.5份、核桃仁4份、决明子油1份、β-胡萝卜素0.5份、绵白糖4份、葡萄糖15份;
制备方法按如下步骤:
1)将小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁和核桃仁,分别烘烤至酥脆,待用;将蛋黄煮熟、加热烘干,待用;
2)按重量份配比称量烘烤后的小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁、核桃仁和蛋黄,加入决明子油,搅拌混合,粉碎,过120目筛得细粉,加入葡萄糖搅拌均匀,即得。
实施例2
由以下重量份的原料制成:小米10份、荞麦5份、芡实3份、蛋黄4份、糙米5份、黑糯米11份、燕麦4份、莲子2份、薏米6份、山药3份、黑豆6份、枸杞子2份、绿茶3份、红枣1份、黑芝麻7份、杏仁0.5份、核桃仁6份、决明子油0.3份、β-胡萝卜素1.5份、绵白糖6份、葡萄糖17份;
优选的,该学生及电脑族用健康粥粉,其特征在于,包括以下重量份的原料:
制备方法按如下步骤:
1)将小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁和核桃仁,分别烘烤至酥脆,待用;将蛋黄煮熟、加热烘干,待用;
2)按重量份配比称量烘烤后的小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁、核桃仁和蛋黄,加入决明子油,搅拌混合,粉碎,过150目筛得细粉,加入葡萄糖搅拌均匀,即得。
实施例3
由以下重量份的原料制成:小米8.5份、荞麦6.5份、芡实1.5份、蛋黄5.5份、糙米3.5份、黑糯米12.5份、燕麦2.5份、莲子3.5份、薏米4.5份、山药4.5份、黑豆4.5份、枸杞子3.5份、绿茶1.5份、红枣2.5份、黑芝麻5.5份、杏仁1.2份、核桃仁4.5份、决明子油0.8份、β-胡萝卜素1.2份、绵白糖5.5份、葡萄糖16份;
制备方法按如下步骤:
1)将小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁和核桃仁,分别烘烤至酥脆,待用;将蛋黄煮熟、加热烘干,待用;
2)按重量份配比称量烘烤后的小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁、核桃仁和蛋黄,加入决明子油,搅拌混合,粉碎,过180目筛得细粉,加入葡萄糖搅拌均匀,即得。
实施例4
由以下重量份的原料制成:小米9.5份、荞麦5.5份、芡实2.5份、蛋黄4.5份、糙米4.5份、黑糯米11.5份、燕麦3.5份、莲子2.5份、薏米5.5份、山药3.5份、黑豆5.5份、枸杞子2.5份、绿茶2.5份、红枣1.5份、黑芝麻6.5份、杏仁0.8份、核桃仁5.5份、决明子油0.4份、β-胡萝卜素0.8份、绵白糖4.5份、葡萄糖17份;
本制备方法按如下步骤:
1)将小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁和核桃仁,分别烘烤至酥脆,待用;将蛋黄煮熟、加热烘干,待用;
2)按重量份配比称量烘烤后的小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁、核桃仁和蛋黄,加入决明子油,搅拌混合,粉碎,过200目筛得细粉,加入葡萄糖搅拌均匀,即得。
实施例5
由以下重量份的原料制成:小米9份、荞麦6份、芡实2份、蛋黄5份、糙米4份、黑糯米12份、燕麦3份、莲子3份、薏米5份、山药4份、黑豆5份、枸杞子3份、绿茶2份、红枣2份、黑芝麻6份、杏仁1份、核桃仁5份、决明子油0.5份、β-胡萝卜素1份、绵白糖5份、葡萄糖16.5份;
制备方法按如下步骤:
1)将小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁和核桃仁,分别烘烤至酥脆,待用;将蛋黄煮熟、加热烘干,待用;
2)按重量份配比称量烘烤后的小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁、核桃仁和蛋黄,加入决明子油,搅拌混合,粉碎,过150目筛得细粉,加入葡萄糖搅拌均匀,即得。
实施例5每100g粥粉中:含有能量1823kJ,蛋白质12.5g,脂肪11.1g,碳水化合物70.6g,钠37.3mg,含水率小于等于4%,硒含量0.080mg。
临床实践总结
以下为本发明的学生及电脑族用健康粥粉可治疗的病症,以及病症的症状表现。
近视眼:远视力明显降低,但近视力尚正常、视力疲劳,双眼干涩,眼睑沉重,眼球酸胀,眼眶疼痛。继而视物模糊,出现双影,看书串行、严重的还可以出现头昏、头痛、恶心,以上症状的一种或多种。
生长障碍:处于生长发育期的青少年,体重持续低于相应年龄体重的第三个百分位数以下;进行性体重下降以至低于第三个百分位点;体重低于相应身高年龄体重的80%;根据患儿原来确定的生长曲线其预期生长值下降,以上症状的一种或多种。
肥胖症:正常体脂标准为男性成人脂肪组织重量占体重的15%~18%,女性占20%~25%,超过该正常体脂标准20%以上。特征是身材外型显得矮胖、浑圆,脸部上窄下宽,双下颏,颈粗短,向后仰头枕部皮褶明显增厚。胸圆,肋间隙不显,双乳因皮下脂肪厚而增大,以上症状的一种或多种。
电脑辐射:面色暗淡;头晕、恶心、视力下降;导致脱发;免疫力下降,内分泌紊乱,以上症状的一种或多种。
失眠:入睡困难、睡眠质量下降和睡眠时间减少。记忆功能下降、注意功能下降、计划功能下降,白天困倦,容易出现日间嗜睡现象,脱发,以上症状的一种或多种。
便秘:便秘时间超过6个月,指排便次数减少、粪便量减少、粪便干结、排便费力,以上症状的一种或多种。
神经衰弱:出现精神易兴奋和脑力易疲乏现象,常伴有情绪烦恼、易激惹、睡眠障碍、肌肉紧张性疼痛,以上症状的一种或多种。
皮肤干燥:皮肤发紧、个别部位干燥脱皮、洗澡过后全身发痒,肤色暗沉,以上症状的一种或多种。
白发:此处说治疗的白发包括青少年白发、青年中年早老性白发、老年白发。初起只有少数白发,随时间推移白发逐渐增多。
临床诊疗报告
本发明的学生及电脑族用健康粥粉的用法:取本发明的学生及电脑族用健康粥粉25g,加开水搅匀,即可食用,一日1~2次,饭前或饭后食用均可。一个月为一个疗程,疗程与疗程之间可连续服用。建议肥胖症患者晚餐时以该健康粥粉代替正餐服用,服用期间需控制饮食,并进行体育运动。
申请人对每个病症选取200例患者进行统计,其中患者年龄10~45岁,男性和女性患者各占50%。疗效判断标准:依上述症状的改善状况将疗效分为治愈、显效和无效,按照前述病症分类使用有效效果所述的疗程内,总有效率为治愈率与显效率之和。每个采用实施例5获得的学生及电脑族用健康粥粉进行临床诊疗,连续使用本发明学生及电脑族用健康粥粉及其制备方法12个疗程后统计,统计结果如表1所示:
表1学生及电脑族用健康粥粉的病例统计
通过表1可看出,治疗有效率为98~100%,证明多数患者在服用本发明的学生及电脑族用健康粥粉病症出现明显改善,生活质量获得了提高。该健康粥粉冲泡后气味香浓、口感香甜软糯,患者乐于长期服用,经统计患者均能坚持服用10~12疗程。
申请人对病例的主要治疗效果统计如下:
近视眼患者服用一周后眼睛感觉不再干涩,服用1个疗程后酸涩消失、近视度数缩减50度,服用12个疗程后配合正确用眼方法、250度以下近视能够恢复正常视力。生长障碍的青少年患者服用1个疗程后代谢正常、睡眠正常、感觉精力充沛,服用12个疗程后,身高、体重达到相应年龄的生长标准。肥胖症患者服用1个疗程后脾胃功能增强、排便正常、体重降低,服用12个疗程后体重恢复正常范围,持续服用肥胖症不易复发,肥胖症患者服用期间需合理饮食,并配合体育运动。电脑辐射患者,服用1个疗程气色改善、眼睛酸痛消失服用6个疗程后精力充沛,气色好、眼睛不适消失、视力恢复、脱发症状消失。失眠患者服用一周睡眠质量明显改善,服用12个疗程后睡眠恢复正常。便秘患者服用1个疗程后排便恢复正常,服用6个月后慢性便秘症状消失,如症状消失可以停止服用。神经衰弱患者服用一周后容易入睡、烦躁感获得改善,服用1~2个疗程后症状消失,如症状消失可以停止服用。皮肤干燥患者服用一周后面色开始红润、皮肤发痒症状缓解,服用1个疗程后面色红润有光泽、皮肤干燥发痒症状明显缓解,服用6个疗程气色有明显改善、肌肤光润有弹性、皮肤干燥发痒症状治愈。白发患者服用1个疗程后部分白发根部变回黑色,服用12个疗程后头发乌黑顺滑、有光泽。
以上所述,仅是本发明的较佳实施例而已,并非是对本发明作其它形式的限制,任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更或改型为等同变化的等效实施例。但是凡是未脱离本发明技术方案内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与改型,仍属于本发明技术方案的保护范围。
Claims (8)
1.学生及电脑族用健康粥粉,其特征在于,包括以下重量份的原料:小米8~10份、荞麦5~7份、芡实1~3份、蛋黄4~6份、糙米3~5份、黑糯米11~13份、燕麦2~4份、莲子2~4份、薏米4~6份、山药3~5份、黑豆4~6份、枸杞子2~4份、绿茶1~3份、红枣1~3份、黑芝麻5~7份、杏仁0.5~1.5份、核桃仁4~6份、决明子油0.3~1份、β-胡萝卜素0.5~1.5份、绵白糖4~6份、葡萄糖15~17份。
2.根据权利要求1所述的学生及电脑族用健康粥粉,其特征在于,包括以下重量份的原料:小米8.5~9.5份、荞麦5.5~6.5份、芡实1.5~2.5份、蛋黄4.5~5.5份、糙米3.5~4.5份、黑糯米11.5~12.5份、燕麦2.5~3.5份、莲子2.5~3.5份、薏米4.5~5.5份、山药3.5~4.5份、黑豆4.5~5.5份、枸杞子2.5~3.5份、绿茶1.5~2.5份、红枣1.5~2.5份、黑芝麻5.5~6.5份、杏仁0.8~1.2份、核桃仁4.5~5.5份、决明子油0.4~0.8份、β-胡萝卜素0.8~1.2份、绵白糖4.5~5.5份、葡萄糖16~17份。
3.根据权利要求1所述的学生及电脑族用健康粥粉,其特征在于,包括以下重量份的原料:小米9份、荞麦6份、芡实2份、蛋黄5份、糙米4份、黑糯米12份、燕麦3份、莲子3份、薏米5份、山药4份、黑豆5份、枸杞子3份、绿茶2份、红枣2份、黑芝麻6份、杏仁1份、核桃仁5份、决明子油0.5份,β-胡萝卜素1份、绵白糖5份、葡萄糖16.5份。
4.根据权利要求1所述的学生及电脑族用健康粥粉,其特征在于:所述的红枣为去核红枣,莲子为去莲芯的莲子,山药为去皮山药。
5.根据权利要求1所述的学生及电脑族用健康粥粉,其特征在于:所述的蛋黄为鸡蛋黄。
6.权利要求1~5任一项所述的学生及电脑族用健康粥粉的制备方法,其特征在于,包括以下步骤:
1)将小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁和核桃仁,分别烘烤至酥脆,待用;将蛋黄煮熟、加热烘干,待用;
2)按重量份配比称量烘烤后的小米、荞麦、芡实、糙米、黑糯米、燕麦、莲子、薏米、山药、黑豆、枸杞子、绿茶、红枣、黑芝麻、杏仁、核桃仁和蛋黄,加入决明子油,搅拌混合,粉碎,过120~200目筛得细粉,加入葡萄糖搅拌均匀,即得。
7.根据权利要求6任一项所述的学生及电脑族用健康粥粉的制备方法,其特征在于:步骤1)所述的杏仁在烘烤前,先加水浸泡24小时。
8.根据权利要求6任一项所述的学生及电脑族用健康粥粉的制备方法,其特征在于:步骤2)中采用过150目筛得细粉。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610587945.7A CN106036435A (zh) | 2016-07-25 | 2016-07-25 | 学生及电脑族用健康粥粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610587945.7A CN106036435A (zh) | 2016-07-25 | 2016-07-25 | 学生及电脑族用健康粥粉及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106036435A true CN106036435A (zh) | 2016-10-26 |
Family
ID=57418070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610587945.7A Pending CN106036435A (zh) | 2016-07-25 | 2016-07-25 | 学生及电脑族用健康粥粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106036435A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109007573A (zh) * | 2018-08-11 | 2018-12-18 | 江西好生食品有限公司 | 一种调节亚健康的五谷类养生代餐粉及其加工工艺 |
CN109007635A (zh) * | 2018-08-13 | 2018-12-18 | 万光瑞 | 一种明目益脑组合物及其制备方法与应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105231443A (zh) * | 2015-09-30 | 2016-01-13 | 灵璧县富成养生坊有限公司 | 一种儿童调理营养粉 |
CN105285952A (zh) * | 2015-10-29 | 2016-02-03 | 华海正元(福建)生物科技有限公司 | 一种营养均衡的代餐粉及其制备方法 |
CN105559076A (zh) * | 2016-02-29 | 2016-05-11 | 山东道之自然健康产业有限公司 | 一种备孕期男性全营养药膳餐糊 |
CN105685789A (zh) * | 2016-02-04 | 2016-06-22 | 北京康仁堂药业有限公司 | 一种五色营养粥粉及其制备方法 |
CN105725043A (zh) * | 2016-02-29 | 2016-07-06 | 山东道之自然健康产业有限公司 | 一种孕前全营养药膳餐糊 |
-
2016
- 2016-07-25 CN CN201610587945.7A patent/CN106036435A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105231443A (zh) * | 2015-09-30 | 2016-01-13 | 灵璧县富成养生坊有限公司 | 一种儿童调理营养粉 |
CN105285952A (zh) * | 2015-10-29 | 2016-02-03 | 华海正元(福建)生物科技有限公司 | 一种营养均衡的代餐粉及其制备方法 |
CN105685789A (zh) * | 2016-02-04 | 2016-06-22 | 北京康仁堂药业有限公司 | 一种五色营养粥粉及其制备方法 |
CN105559076A (zh) * | 2016-02-29 | 2016-05-11 | 山东道之自然健康产业有限公司 | 一种备孕期男性全营养药膳餐糊 |
CN105725043A (zh) * | 2016-02-29 | 2016-07-06 | 山东道之自然健康产业有限公司 | 一种孕前全营养药膳餐糊 |
Non-Patent Citations (2)
Title |
---|
苏易: "《五谷杂粮巧搭配》", 31 January 2014, 团结出版社 * |
顾奎琴: "《中华家庭药膳全书》", 31 January 2005, 中医古籍出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109007573A (zh) * | 2018-08-11 | 2018-12-18 | 江西好生食品有限公司 | 一种调节亚健康的五谷类养生代餐粉及其加工工艺 |
CN109007635A (zh) * | 2018-08-13 | 2018-12-18 | 万光瑞 | 一种明目益脑组合物及其制备方法与应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107173694A (zh) | 一种营养全面平衡的全素食代餐粉配方 | |
CN106136048A (zh) | 中老年用健康粥粉及其制备方法 | |
CN110447902B (zh) | 一种具有减肥功效的组合物 | |
CN106173733A (zh) | 一种黑木耳养生保健饮料及其制备方法 | |
CN106213501A (zh) | 一种营养羹及其制备方法 | |
CN103405728B (zh) | 一种治疗更年期综合症的中药组合物及其制备方法 | |
CN106036429A (zh) | 一种用于减肥的保健品及其制备方法 | |
CN104225361A (zh) | 一种丹七养生酒及其制备方法 | |
CN106360286A (zh) | 一种营养组合物及其制备方法和应用 | |
CN107223846A (zh) | 一种适合中老年人的杂粮保健粉 | |
CN106579395A (zh) | 补肾生发乌发的营养粉及其制备方法 | |
CN113925163A (zh) | 具有健脾养胃、益气生血功能的组合物、食品及制备方法 | |
CN111184176A (zh) | 基于体质学说用于九种不同体质的速食型养生食品组合物 | |
CN105851436A (zh) | 一种补硒牛皮糖 | |
CN106036435A (zh) | 学生及电脑族用健康粥粉及其制备方法 | |
CN107596197A (zh) | 一种补气解郁茶及其制备方法 | |
CN102293996B (zh) | 用于小儿厌食症的外敷鸡麦香皮粉 | |
CN100571526C (zh) | 一种保健茶 | |
CN105581304A (zh) | 一种补脾养血安神汤及其制备方法 | |
CN109007573A (zh) | 一种调节亚健康的五谷类养生代餐粉及其加工工艺 | |
CN105941566A (zh) | 一种防治糖尿病的保健饼干及其制作方法 | |
CN106072290A (zh) | 一种可减少孕吐又可补充营养的羹汤及制备方法 | |
CN103734609B (zh) | 增强心脑供血,供氧,健脾补气,养血补肾药食同膳面 | |
CN105851336A (zh) | 铁皮石斛茶及其制备方法 | |
CN106234896A (zh) | 一种治疗肾病的保健饮品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161026 |